MedTrace Logo

Ropivacaine Hypobaric Spinal Anaesthesia in Traumatic Hip Surgery

NCT01005550 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2019-05-28

No results posted yet for this study

Summary

This is a prospective, monocentric, randomized study, comparing the effectiveness and tolerance of four different dosages of hypobaric ropivacaine for unilateral spinal anaesthesia during traumatic femoral neck surgery in the elderly.

Conditions

  • Femoral Neck Fracture

Interventions

DRUG

6 mg of ropivacaine

6 mg of ropivacaine are used for the spinal anaesthesia

DRUG

8 mg of ropivacaine

8 mg of ropivacaine are used for the spinal anaesthesia

DRUG

10 mg of ropivacaine

10 mg of ropivacaine for the spinal anaesthesia

DRUG

12 mg of ropivacaine

12 mg of ropivacaine for the spinal anaesthesia

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Principal Investigators

  • Pascal MEURET, MD · Hospices Civils de Lyon

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01005550 on ClinicalTrials.gov